SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D ...
Two-wheel vehicles are now changing and evolving perhaps faster than ever before, with ambitious startups all over the world ready to shake things up with disruptive designs and technologies. One of ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix, a technology innovation company pioneering innovative tools enabling efficient, cost-effective, and large-scale production of viral vectors for ...
In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min “This is an opportunity for me ...
SAN FRANCISCO, June 24, 2025 – Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with ...
MELBOURNE, Australia & PERTH, Australia, March 18, 2025--(BUSINESS WIRE)--Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell ...
Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem ...
SAN JOSE, Calif., March 10 /PRNewswire/ — Xilinx Inc. (Nasdaq: XLNX) today announced immediate availability of the latest edition of its quarterly Xcell Journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback